Leuko

📍 Boston, United States🗓 Founded 2017👥 14 employees💰 Last funded Aug 2022
Medical Equipment Manufacturing🌐 leuko.io
Website LinkedIn
Leuko is developing the first non-invasive white blood cell device. White blood cell assessment is a first-line indicator for various medically-relevant situations, ranging from chemotherapy management to the detection of life threatening infections worldwide. This test is currently invasive and not readily accessible - it requires patient travel, blood draws and laboratory infrastructure. Based on MIT research, Leuko is re-imagining the way to perform these tests without extracting blood and in a portable device.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2017
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Italy
1
Spain
1
Frequently asked questions
Who invested in Leuko?
Leuko has 2 investors on record on gritt.io, 2 mid-stage.
When did Leuko last raise funding?
The most recent investment in Leuko recorded on gritt.io was in August 2022.
When was Leuko founded?
Leuko was founded in 2017.
What industry is Leuko in?
Leuko operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Leuko based?
Leuko is headquartered in Boston, United States.